RVTY Revvity Inc

  1. Stocks
  2. Healthcare
  3. NYSE: RVTY

Price (delayed)

$145.96

Market cap

$16.29B

P/E Ratio

69.84

Dividend/share

$0.28

EPS

$2.09

Enterprise value

$18.61B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 51

The PerkinElmer Life Sciences and Diagnostics company – which is to be renamed during the second quarter of 2023 – provides end-to-end solutions that help scientists, researchers and clinicians better ...

Highlights
The company's revenue rose by 4.1% YoY
The gross profit has grown by 2.3% YoY
The quick ratio has decreased by 45% YoY but it has increased by 9% QoQ
The stock's price to earnings (P/E) is 76% more than its 5-year quarterly average of 38.6 and 46% more than its last 4 quarters average of 46.5
Revvity's net income has decreased by 17% YoY
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.perkinelmer.com
Peers: QTRX PRPO MTD

Key stats

What are the main financial stats of RVTY

RVTY stock price

How has the Revvity stock price performed over time
Intraday
2.71%
1 week
-0.52%
1 month
18.67%
1 year
72.75%
YTD
50.86%
QTD
31.19%

Financial performance

How have Revvity's revenue and profit performed over time
Revenue
$2.91B
Gross profit
$1.6B
Operating income
$358.85M
Net income
$237.55M
Gross margin
55%
Net margin
8.2%
RVTY's net margin is down by 20% year-on-year
Revvity's net income has decreased by 17% YoY
The company's operating margin fell by 10% YoY
The company's operating income fell by 6% YoY

Price vs fundamentals

How does RVTY's price correlate with its fundamentals

Growth

What is Revvity's growth rate over time

Valuation

What is Revvity stock price valuation
RVTY P/E details
P/E
69.84
P/B
2.25
P/S
5.59
EV/EBIT
51.82
EV/EBITDA
24.12
EV/Sales
6.39
The stock's price to earnings (P/E) is 76% more than its 5-year quarterly average of 38.6 and 46% more than its last 4 quarters average of 46.5
The EPS has contracted by 11% YoY
The price to book (P/B) is 46% higher than the last 4 quarters average of 1.5 and 10% higher than the 5-year quarterly average of 2.0
The equity is down by 4.3% year-on-year
The price to sales (P/S) is 43% higher than the last 4 quarters average of 3.8 and 14% higher than the 5-year quarterly average of 4.8
The company's revenue rose by 4.1% YoY

Efficiency

How efficient is Revvity business performance
The company's return on assets fell by 13% YoY
The ROS has contracted by 11% YoY
RVTY's return on equity is down by 11% year-on-year
RVTY's return on invested capital is up by 3.8% year-on-year and by 2.5% since the previous quarter

Dividends

What is RVTY's dividend history
Dividend details
DPS
$0.28
Dividend yield
0.19%
Payout ratio
13.4%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Revvity financials performed over time
The total assets is 150% greater than the total liabilities
The current ratio has contracted by 46% YoY but it has grown by 4.7% from the previous quarter
The quick ratio has decreased by 45% YoY but it has increased by 9% QoQ
RVTY's debt is 54% smaller than its equity
The equity is down by 4.3% year-on-year
RVTY's debt to equity is up by 2.2% year-on-year but it is down by 2.1% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.